Prolatis recalls male-enhancement product

SALT LAKE CITY Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under the brand name Prolatis’ after being informed by the Food and Drug Administration that lab analysis has found their male-enhancement products to contain sulfoaildenafil, an analogue of sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction.

That makes Prolatis’ an unapproved drug, as opposed to a dietary supplement.

The active drug ingredient is not listed on the product label. Product manufactured prior to Aug. 9, 2010 is included in this recall. Prolatis’ is sold nationwide in double blister packs and 40-count bottles at “GNC and other smarter retailers” according to the company’s website. Prolatis’ had also been sold on CVS.com.

The recall is being conducted as a precautionary measure, the company asserted.